Literature DB >> 21763571

Diffuse hyperpigmented plaques as cutaneous manifestation of multicentric Castleman disease and treatment with thalidomide: report of three cases.

Xiaoqing Zhao1, Ruofei Shi1, Xiaolong Jin2, Jie Zheng3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21763571     DOI： 10.1016/j.jaad.2010.01.012

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  4 in total

1.  Salvage therapy with lenalidomide containing regimen for relapsed/refractory Castleman disease: a report of three cases.

Authors:  Xinping Zhou; Juying Wei; Yinjun Lou; Gaixiang Xu; Min Yang; Hui Liu; Liping Mao; Hongyan Tong; Jie Jin
Journal:  Front Med       Date:  2017-04-03       Impact factor: 4.592

2.  Co-Existence of Multicentric Castleman's Disease and Kaposi's Sarcoma.

Authors:  Reza Yaghoobi; Nader Pazyar; Sadigheh Tavakoli
Journal:  Indian J Dermatol       Date:  2015 May-Jun       Impact factor: 1.494

3.  Thalidomide for tocilizumab-resistant ascites with TAFRO syndrome.

Authors:  Shotaro Tatekawa; Koji Umemura; Ryuichi Fukuyama; Akio Kohno; Masafumi Taniwaki; Junya Kuroda; Yoshihisa Morishita
Journal:  Clin Case Rep       Date:  2015-04-22

4.  Idiopathic multicentric Castleman disease with pulmonary and cutaneous lesions treated with tocilizumab: A case report.

Authors:  Ping-Yang Han; Hui-Hui Chi; Yu-Tong Su
Journal:  World J Clin Cases       Date:  2020-10-26       Impact factor: 1.337
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.